Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of the Treatment of Oral Erosive Lichen Planus With 1% Pimecrolimus Cream: a Double Blind Randomized Prospective Trial With Measurement of Pimecrolimus Levels in the Blood

NCT00321750 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.

NCT NCT00321750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00321750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of the Treatment of Oral Erosive Lichen Planus With 1% Pimecrolimus Cream: a Double Blind Randomized Prospective Trial With Measurement of Pimecrolimus Levels in the Blood
Lead sponsor
Centre Hospitalier Universitaire de Nice
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2004
Completion date
April 30, 2005
Enrollment
14
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

oral erosive lichen planus